Educational Track and Pro & Con Debates
Monday 7th June 2010
10.05 - 11.05
Educational Track: Chinese 1
"Comprehensive intervention schizophrenia, strategies integration with Chinese context"
Chairman:
Xin Yu, Beijing, China
Speakers:
Yuan Yanbo, China
Jingping Zhao, Hunan, China
10.05 - 11.05
Educational Track: Korean 1
"Drug responses and adverse effects from pharmacogenetic perspectives"
Chairman:
Min Cheol Park, Cheonbuk, Korea
Speakers:
Yeon Ho Joo, Korea - "Comparison of schizophrenia and bipolar disorder with regards to drug response"
Kyung Sue Hong - "Pharmacogenetic approaches to adverse effects of antipsychotics"
10.05 - 11.05
Educational Track: Japanese 1
"How to use assessment tools for cognitive function of schizophrenia"
Chairman:
Tetsuro Ohmori
Speakers:
Yasuhiro Kaneda, Japan - "Brief lecture and practice of BACS"
Ichiro Sora, Japan - "Brief lecture and practice of MATRICS"
11.15 - 12.15
Educational Track: English 1
"Recent advances in the psychopharmacology of bipolar disorder"
Speaker:
Philip Mitchell, Australia
14.50 - 15.50
Educational Track: English 2
"Metabolic side affects of antipsychotic drugs"
Speaker:
Vidar Steen, Norway
15.50 - 16.50
Pro & Con Debate
"Should psychopharmacology concern itself with treating disease or promoting human well being?"
Moderator:
Edmond Pi, USA
Debators:
Dilip Jeste, USA
David Healy, UK
Tuesday 8th June 2010
10.05 - 11.05
Educational Track: Chinese 2
"New durg clinical trials in China, perspective and special consideration"
Chairman:
Si Tianmei, Beijing, China
Speakers:
Li Huafang, Shanghai, China
Wang Gang, China
10.05 - 11.05
Educational Track: Korean 2
"Current trend of clinical trial in psychiatry"
Chairman:
Min-Soo Lee, Seoul, Korea
Speakers:
Sung-Wan Kim, Gwangju, Korea - "Current trend of clinical trial of antipsychotics in patients with schizophrenia"
Yong Min Ahn, Seoul, Korea - "Issues about clinical trials in patients with bipolar disorders"
10.05 - 11.05
Educational Track: Japanese 2
"How to use assessment tools for anxiety disorders"
Chairman:
Satsuki Sumitani, Tokushima, Japan
Speakers:
Satoshi Asakura, Hokkaido, Japan - "Brief lecture and practice of LSAS"
Chiaki Taga, Kyoto, Japan - "Brief lecture and practice of Y-BOCS"
11.15 - 12.15
Educational Track: English 3
"The role of thyroid hormones in depression and its treatment"
Speaker:
Bernard Lerer, Israel
14.50 - 15.50
Educational Track: English 4
"Imaging in psychiatry"
Speaker:
Lars Farde, Sweden
15.50 - 16.50
Pro & Con Debate
"GSK-3 vs. inositol phosphates as targets of mood stabilising drugs"
Moderator:
Yechiel Levkovitz, Israel
Speaker:
Peter Klein, USA
Adrian Harwood, UK
Wednesday 9th June 2010
10.05 - 11.05
Educational Track: Chinese 3
"Individualisation therapy in China, what is special or general?"
Chairman:
Jingping Zhao, Hunan, China
Speakers:
Li Tao, China
Si Tianmei, Beijing, China
10.05 - 11.05
Educational Track: Korean 3
"Recent perspectives on the neurobiology and treatment of anxiety disorders"
Chairman:
Jong Huk Choi, Korea
Speakers:
Kang Seob Oh, Korea - "The newer understanding on the neurobiology of anxiety disorders"
Jong-Chul Yang, Korea - "The newer treatment options in the treatment of anxiety disorders"
10.05 - 11.05
Educational Track: Japanese 3
"How to use clinical evidences in pharmacotherapy of psychiatric disorders"
Chairman:
Koichiro Watanabe, Tokyo, Japan
Speakers:
Hiroyoshi Takeuchi, Tokyo, Japan - "How to critically appraise an article in psychopharmacotherapy"
Toshiaki Kikuchi, Tokyo, Japan - "How to apply the results to yuor patient"
11.15 - 12.15
Educational Track: English 5
TBC
14.50 - 15.50
Educational Track: English 6
"How to understand neural circuits and their implications for psychiatric disorders"
Speaker:
Anthony Grace, USA
Thursday 10th June 2010
09.00 - 11.00
Educational Track: English 7
"Conducting CNS clinical trials in Asia - Opportunities and Challenges"
Chairman: David Daniel, USA
Co-Chairman: Hua Jin, USA
Speakers:
David Daniel, USA
Hua Jin, USA
Teruhiko Higuchi, Japan
Vikas Sharma,, India
Amir Kalali, USA - "15 Years of Experience Conducting Industry CNS Clinical Trials in Asia: What Are the Trends, and What Have We Learned?"



